Juliana Maynard

Preclinical Pharmacology of AZD5363, an Inhibitor of AKT: Pharmacodynamics, Antitumor Activity, and Correlation of Monotherapy Activity with Genetic Background

Barry R. Davies, Hannah E. Greenwood, Phillippa Dudley et al. · Molecular Cancer Therapeutics · 2012 · 453 citations

Pharmacotherapy, Cancer Biology, Tumor Biology +18

Micro-CT Imaging of Tumor Angiogenesis

Josef Ehling, Benjamin Theek, Felix Gremse et al. · American Journal Of Pathology · 2013 · 148 citations · Full text

Ultrasound-triggered therapeutic microbubbles enhance the efficacy of cytotoxic drugs by increasing circulation and tumor drug accumulation and limiting bioavailability and toxicity in normal tissues

Nicola Ingram, Laura E. McVeigh, Radwa H. Abou‐Saleh et al. · Theranostics · 2020 · 62 citations · Full text

Combined Inhibition of PI3Kβ and mTOR Inhibits Growth of PTEN-null Tumors

James T. Lynch, Urszula M. Polanska, Ursula Hancox et al. · Molecular Cancer Therapeutics · 2018 · 26 citations

Examining Changes in [18 F]FDG and [18 F]FLT Uptake in U87-MG Glioma Xenografts as Early Response Biomarkers to Treatment with the Dual mTOR1/2 Inhibitor AZD8055

Heather Keen, Sally‐Ann Ricketts, Juliana Maynard et al. · Molecular Imaging and Biology · 2013 · 20 citations

Oncology, Oncologic Imaging, U87-mg Glioma Xenografts +10